Skip to main content
Clinical Trials/CTRI/2024/01/061162
CTRI/2024/01/061162
Completed
Phase 4

A Clinical Study to evaluate the 8-hour moisturization potential of Multiple SaliguardSamples at concentration 1.5% - NI

Salicylates & Chemicals Pvt. Ltd.0 sites0 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Not specified
Sponsor
Salicylates & Chemicals Pvt. Ltd.
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Salicylates & Chemicals Pvt. Ltd.

Eligibility Criteria

Inclusion Criteria

  • 1\) Gender: Male or Female with age 18\-40
  • 2\) Subjects willing to give written informed consent
  • 3\) Women of child bearing potential must have a negative urine
  • pregnancy test prior to study entry.
  • 4\) Are free of any systemic or dermatologic disorder, which, in
  • the opinion of the investigator, will interfere with the study
  • results or increase the risk of adverse events.
  • 5\) Are willing to avoid prolonged exposure of the treatment area
  • to ultraviolet radiation (natural or artificial) for the duration of

Exclusion Criteria

  • 1\. Subjects who are pregnant, breast\-feeding, or planning to become pregnant during the study.
  • 2\. Have any evidence of systemic cancer, squamous cell carcinoma, basal cell carcinoma, in the last 5 years, or any other confounding skin condition.
  • 3\. Have open sores or open lesions in the treatment area(s).
  • 4\. Have any condition that, in the opinion of the investigator, would confound the safety and efficacy assessments of the
  • 5\. Have participated in any interventional clinical trial in the previous 90 days.
  • 6\. Have a known sensitivity to any of the constituents of the test product.
  • 7\. Have used, are using, or are planning to use
  • immunosuppressive or immunomodulatory medication (i.e.,biologics), including corticosteroids.
  • 8\. Have not skin related issues

Outcomes

Primary Outcomes

Not specified

Similar Trials